(C001) Lyxor Core DAX (DR) - Ratings and Ratios
Equity, Germany, Index, Large-cap, ETFs
Description: C001 Lyxor Core DAX (DR)
The Lyxor Core DAX (DR) UCITS ETF is a Germany Equity ETF that tracks the DAX index, providing investors with exposure to the German equity market. With an AUM of €1.076 billion, it is a sizable fund that offers liquidity, as evident from its average trading volume of 17,330 shares on XETRA.
The ETFs performance is closely tied to the German economy, which is driven by key sectors such as automotive, mechanical engineering, and chemicals. The DAX index, comprising the top 30 German companies, is a widely followed benchmark that reflects the countrys economic health. As such, the ETFs returns are influenced by factors like GDP growth, industrial production, and employment rates in Germany.
To evaluate the ETFs potential, investors should monitor key economic indicators, such as the Ifo Business Climate Index, which surveys German businesses on their current and future prospects. Additionally, the European Central Banks monetary policy decisions and global trade developments can impact the ETFs performance. From a technical analysis perspective, the ETFs price action and trends can be assessed using indicators like the Relative Strength Index (RSI) and Moving Average Convergence Divergence (MACD).
Investors should also consider the ETFs tracking error, expense ratio, and dividend yield when making investment decisions. A low tracking error indicates that the ETF is effectively replicating the DAX index, while a competitive expense ratio helps minimize costs. The dividend yield, which is influenced by the underlying constituents payout policies, can provide a regular income stream for investors.
C001 ETF Overview
| Market Cap in USD | 1,263m |
| Category | Germany Equity |
| TER | 0.08% |
| IPO / Inception | 2008-08-21 |
C001 ETF Ratings
| Growth Rating | 90.9% |
| Fundamental | - |
| Dividend Rating | 50.7% |
| Return 12m vs S&P 500 | 5.01% |
| Analyst Rating | - |
C001 Dividends
| Dividend Yield 12m | 1.89% |
| Yield on Cost 5y | 3.22% |
| Annual Growth 5y | 3.33% |
| Payout Consistency | 92.8% |
| Payout Ratio | % |
C001 Growth Ratios
| Growth Correlation 3m | -6.6% |
| Growth Correlation 12m | 91.9% |
| Growth Correlation 5y | 80.4% |
| CAGR 5y | 23.44% |
| CAGR/Max DD 3y | 1.48 |
| CAGR/Mean DD 3y | 17.11 |
| Sharpe Ratio 12m | 0.76 |
| Alpha | 0.02 |
| Beta | 0.777 |
| Volatility | 12.37% |
| Current Volume | 9.2k |
| Average Volume 20d | 11.3k |
| Stop Loss | 172.6 (-3.1%) |
| Signal | -1.83 |
What is the price of C001 shares?
Over the past week, the price has changed by -1.58%, over one month by -4.02%, over three months by -1.59% and over the past year by +24.67%.
Is Lyxor Core DAX (DR) a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of C001 is around 193.67 EUR . This means that C001 is currently overvalued and has a potential downside of 8.78%.
Is C001 a buy, sell or hold?
What are the forecasts/targets for the C001 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 216.7 | 21.7% |
C001 Fundamental Data Overview
Market Cap EUR = 1.08b (1.08b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.96
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.08b EUR (1.08b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 1.08b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.08b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(1.08b)/V(0.0) * Re(8.88%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.88% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)